Breast Cancer

1:41
Avoiding chemotherapy in the treatment of breast cancer
Peter Fasching
1:40
Early RIBECCA results: ribociclib with letrozole for metastatic breast cancer
Peter Fasching
2:45
Trial updates in breast cancer from ASCO: TAILORx, PAKT, MONARCH 2 & MONALEESA-3
Robert Coleman
3:13
Breast cancer: new advances in personalized medicine and therapeutics
Howard Burris
3:36
Final results of PAKT: capivasertib and paclitaxel for TNBC
Peter Schmid
3:49
Precision medicine is the future of cancer treatment
Howard Burris
3:59
Sacituzumab govitecan for treatment-refractory metastatic breast cancer
Aditya Bardia
2:18
Metastatic breast cancer: promising therapeutic avenues
Aditya Bardia
1:56
PERSEPHONE: 6 vs. 12-month adjuvant trastuzumab in early breast cancer
Robert Coleman
3:27
Early breast cancer treatment: denosumab
Robert Coleman
2:40
Immunotherapy in common solid tumors: an overview
Elaine Vickers
1:28
Genetic testing for breast and ovarian cancer: tackling the challenges to availability
Nazneen Rahman
1:16
Improving pathways for the genetic testing of breast and ovarian cancer
Nazneen Rahman
4:21
A study of chemotherapy-induced peripheral neuropathy: support needs after cancer treatment
Mary Tanay
5:07
Recruiting for cancer research lifestyle programs
Annie Anderson
4:12
The importance of lifestyle intervention trials in cancer survivors
Annie Anderson
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals